Concepedia

Aliya Holland

AH

Statistics

Publications

4

Citations

182

H-Index

4

Active since

2020

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Parker Institute for Cancer Immunotherapy

Icahn School of Medicine at Mount Sinai

Swim Across America

Aliya Holland is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and tumor immunology.

Publications per year

2020–2024

4

Publications

4

In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response

Aditi Sahu, Lukas Kraehenbuehl, Candice Byers et al. · Nature Communications · 2022 · 55 citations · Full text

, , +17

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial

Dmitriy Zamarin, Sven Walderich, Aliya Holland et al. · Journal for ImmunoTherapy of Cancer · 2020 · 54 citations · Full text

, , +17

Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors

Diwakar Davar, Roberta Zappasodi, Hong Wang et al. · Clinical Cancer Research · 2022 · 48 citations · Full text

, , +16

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses

Claire F. Friedman, Beryl Manning‐Geist, Qin Zhou et al. · Nature Medicine · 2024 · 25 citations · Full text

, , +14

1–4 of 4